Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Depreciation and Depletion: 2009-2023

Historic Depreciation and Depletion for Assembly Biosciences (ASMB) over the last 15 years, with Dec 2023 value amounting to $500,000.

  • Assembly Biosciences' Depreciation and Depletion rose 200.00% to $300,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $600,000, marking a year-over-year increase of 50.00%. This contributed to the annual value of $500,000 for FY2023, which is negligibly% changed negligibly from last year.
  • Assembly Biosciences' Depreciation and Depletion amounted to $500,000 in FY2023, which was down 0.00% from $500,000 recorded in FY2022.
  • In the past 5 years, Assembly Biosciences' Depreciation and Depletion registered a high of $700,000 during FY2020, and its lowest value of $500,000 during FY2019.
  • Over the past 3 years, Assembly Biosciences' median Depreciation and Depletion value was $500,000 (recorded in 2023), while the average stood at $500,000.
  • As far as peak fluctuations go, Assembly Biosciences' Depreciation and Depletion spiked by 40.00% in 2020, and later decreased by 28.57% in 2021.
  • Over the past 5 years, Assembly Biosciences' Depreciation and Depletion (Yearly) stood at $500,000 in 2019, then surged by 40.00% to $700,000 in 2020, then dropped by 28.57% to $500,000 in 2021, then remained steady at $500,000 in 2022, then remained steady at $500,000 in 2023.